| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/24/2009 | WO2009115321A1 Midazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators |
| 09/24/2009 | WO2009115301A1 Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
| 09/24/2009 | WO2009115280A1 Remineralizing saliva substitute and method for the production thereof |
| 09/24/2009 | WO2009115272A1 Remineralizing dental care product and method for the production thereof |
| 09/24/2009 | WO2009115257A1 Substituted sulfonamide derivatives |
| 09/24/2009 | WO2009115252A2 Substituted pyrazolamides and the use thereof |
| 09/24/2009 | WO2009115235A1 Pde inhibitors for the treatment of pulmonary hypertension |
| 09/24/2009 | WO2009115213A1 (pyrazolyl carbonyl)imidazolidinone derivatives for the treatment of retroviral diseases |
| 09/24/2009 | WO2009115051A1 Antifouling method and composition using chromen-4-one derivatives |
| 09/24/2009 | WO2009115023A1 A anthocyanins phospholipid complex and the preparative method thereof |
| 09/24/2009 | WO2009114994A1 The use of the pyridazinone derivatives for the manufacture of medicament for anti-tumour |
| 09/24/2009 | WO2009114993A1 Pyridazinones, the preparation and the use thereof |
| 09/24/2009 | WO2009114981A1 Process for preparing sulfoxide compounds |
| 09/24/2009 | WO2009114950A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |
| 09/24/2009 | WO2009114924A1 Antiseptic compositions for the treatment of infections |
| 09/24/2009 | WO2009114921A1 INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES |
| 09/24/2009 | WO2009097233A9 Imidazopyrazines as protein kinase inhibitors |
| 09/24/2009 | WO2009096817A3 Agent for reducing the degree of acute alcoholic intoxication (inebriation) and the use thereof |
| 09/24/2009 | WO2009087285A4 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 09/24/2009 | WO2009087212A3 Pyridine derivatives |
| 09/24/2009 | WO2009085828A3 Quinine sulfate polymorphs, processes of preparing, compositions and uses thereof |
| 09/24/2009 | WO2009085270A3 Use of inhibitors of c0nnexin43 for treatment of fibrotic conditions |
| 09/24/2009 | WO2009084040A4 Once a day formulation of angiotensin receptor blockers |
| 09/24/2009 | WO2009083608A9 Quinazolines and related heterocyclic compounds, and their therapeutic use |
| 09/24/2009 | WO2009083268A3 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative |
| 09/24/2009 | WO2009081065A3 Method of preparing a material formed from branched molecules comprising associative groups |
| 09/24/2009 | WO2009080705A3 Bis-thiazole derivatives, process for their preparation and their use as medicaments |
| 09/24/2009 | WO2009077559A3 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators |
| 09/24/2009 | WO2009074794A3 Anti-inflammatory compositions and combinations |
| 09/24/2009 | WO2009074662A3 Organic compounds |
| 09/24/2009 | WO2009073820A3 Biopolymer-nucleic acid conjugation |
| 09/24/2009 | WO2009071607A3 Ergoline derivatives as selective radical scavengers for neurons |
| 09/24/2009 | WO2009070314A3 Crystalline form of sitagliptin |
| 09/24/2009 | WO2009068682A3 Phenyl-oxetanyl-derivatives |
| 09/24/2009 | WO2009068520A3 Polymorphic form of rotigotine |
| 09/24/2009 | WO2009067397A3 Treatment for solid tumors |
| 09/24/2009 | WO2009067221A3 Microemulsion containing indolocarbazole compound and dosage forms containing the same |
| 09/24/2009 | WO2009067035A3 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition |
| 09/24/2009 | WO2009066315A3 Sustained release compositions of trimetazidine and process for preparation thereof |
| 09/24/2009 | WO2009065921A3 Novel compounds |
| 09/24/2009 | WO2009064486A3 Inhibitors of pim protein kinases, compositions, and methods for treating cancer |
| 09/24/2009 | WO2009063333A3 Compositions and methods to increase bioavailability of carotenoids |
| 09/24/2009 | WO2009063081A3 Composition comprising at least one nucleosidic moiety as a therapeutic agent, and ckc. |
| 09/24/2009 | WO2009063028A3 Substituted amides, manufacturing and use thereof as medicaments |
| 09/24/2009 | WO2009062990A3 Equilibrative nucleoside transporter ent1 inhibitors |
| 09/24/2009 | WO2009061852A3 Modulation of factor 9 expression |
| 09/24/2009 | WO2009057139A3 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
| 09/24/2009 | WO2009055568A3 Liposomal vancomycin formulations |
| 09/24/2009 | WO2009053443A3 Indane compounds |
| 09/24/2009 | WO2009047802A3 Novel colon targeted modified release bioadhesive formulation of 5-amino salicylic acid or its salts and metabolites thereof |
| 09/24/2009 | WO2009047291A3 Use of quaternary pyridinium salts for inhibiting cancer metastases |
| 09/24/2009 | WO2009045655A3 Compositions containing purine nucleosides and manganese and their uses |
| 09/24/2009 | WO2009045457A3 Tripartite rnai constructs |
| 09/24/2009 | WO2009039248A3 Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection |
| 09/24/2009 | WO2009035949A3 Soluble epoxide hydrolase inhibitors |
| 09/24/2009 | WO2009032668A3 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
| 09/24/2009 | WO2009027077A3 5-arylalkylidene-2-arylalkyl-thiazol-4-one derivatives as inhibitors of 5-lipoxygenase and uses thereof |
| 09/24/2009 | WO2009026427A3 Liposome compositions for in vivo administration of boronic acid compounds |
| 09/24/2009 | WO2009024611A3 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use |
| 09/24/2009 | WO2009023844A3 3' substituted compounds having 5-ht6 receptor affinity |
| 09/24/2009 | WO2009005674A3 Novel hiv reverse transcriptase inhibitors |
| 09/24/2009 | WO2008151288A3 Aromatic and heteroaromatic compounds useful in treating iron disorders |
| 09/24/2009 | WO2008144423A3 Compositions comprising a gpr109 ligand for treating disorders of the digestive tract and/or cancer |
| 09/24/2009 | WO2008143992A3 Improved depot formulations |
| 09/24/2009 | WO2008140772A3 Robust rapid disintegration tablet formulation |
| 09/24/2009 | WO2008134828A3 Tissue degeneration protection |
| 09/24/2009 | WO2008129468A9 Pharmaceutical compositions of clopidogrel |
| 09/24/2009 | WO2008128627A3 Topically applicable fungicide agents for treating nails |
| 09/24/2009 | WO2008121029A3 Use of 9-oxoacridine-10-acetic acid and/or salts and/or its esters thereof for the treatment and prophylaxis of malignant tumors of female reproductive system |
| 09/24/2009 | WO2008116601A4 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof |
| 09/24/2009 | WO2008113469A8 Substituted imidazopyrimidines and triazolopyrimidines |
| 09/24/2009 | WO2008065636A3 Treatment of disease by modulating cf5 protein |
| 09/24/2009 | WO2008030119A9 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 09/24/2009 | WO2007136988A8 Compounds and methods for modulating expression of gccr |
| 09/24/2009 | US20090240053 2-(4-(1-methyl-4-piperidinoxy)benzylamino)-2-methyl-propanamide; nervous system disorders; analgesics; anticonvulsants; sodium channel moderators; antidepressants, antiarrhythmics and for the treatment or prevention of diabetic neuropathy |
| 09/24/2009 | US20090240051 New process for the production of oxabispidines |
| 09/24/2009 | US20090239956 Lamellar type liquid crystal composition for cosmetic |
| 09/24/2009 | US20090239955 Novel obovatol derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for the prevention and treatment of cancer containing the same as an active ingredient |
| 09/24/2009 | US20090239953 Use of an anti-cancer compound |
| 09/24/2009 | US20090239952 Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy |
| 09/24/2009 | US20090239951 Crystalline Material |
| 09/24/2009 | US20090239950 Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
| 09/24/2009 | US20090239949 Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same |
| 09/24/2009 | US20090239947 Inhibition of proliferation and fibrotic response of activated corneal stromal cells |
| 09/24/2009 | US20090239946 Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitors chelate complexes |
| 09/24/2009 | US20090239945 Oral Composition with an Antiageing Effect on the Skin |
| 09/24/2009 | US20090239944 Novel Use of Organic Compounds |
| 09/24/2009 | US20090239943 Nutraceutical composition and methods for its use |
| 09/24/2009 | US20090239942 Topiramate Compositions and Methods of Making and Using the Same |
| 09/24/2009 | US20090239941 Amino acid derivatives |
| 09/24/2009 | US20090239940 Treating heart failure and ventricular arrhythmias |
| 09/24/2009 | US20090239939 Combinations for introducing nucleic acids into cells |
| 09/24/2009 | US20090239938 Preventive/remedy for arteriosclerosis |
| 09/24/2009 | US20090239937 Apoptosis-Inducing Genes for Treating Cancer |
| 09/24/2009 | US20090239936 Prophylactic and Therapeutic Agent for Cancer |
| 09/24/2009 | US20090239935 Rna-helicase as a marker for rare tumors |
| 09/24/2009 | US20090239934 Anti-Myosin Va siRNA and Skin Depigmentation |
| 09/24/2009 | US20090239933 Hepatitis c antivirals |
| 09/24/2009 | US20090239932 Antisense oligonucleotides against protein kinase isoforms alpha, beta and gamma |
| 09/24/2009 | US20090239931 For modulating protein tyrosine phosphatase-1B (PTP-1B) gene expression ; nucleic acids with a pyrimidine modification; obesity, insulin resistance, diabetes (type II and type I diabetes) |